SGD PharmaCompany NewsSGD Pharma upgrades its Chinese plant toward an automated and improved productionSGD Pharma's Zhanjiang (China) plant produces 1.2 million Type II & III flint molded glass vials dai...
SGD PharmaCompany NewsSGD Pharma shortlisted for the CPhI Pharma AwardsWe are thrilled to announce that SGD Pharma has been shortlisted as a finalist in the Packaging cate...
SGD PharmaCompany NewsSGD Pharma introduces Clareo, its new premium range of molded glass vials in Type II, for injectable solutionsClareo vials from SGD Pharma offer a combination of homogeneous wall thickness and superior cosmetic...
SGD PharmaCompany NewsJIC enters into exclusive discussions with Oaktree to acquire SGD PharmaChina Jianyin Investment Ltd. (“JIC”), a long-term investor, enters into exclusive discussions with ...
SGD PharmaInterviewAn interview with Dr Karl Leitner, head of production, OctapharmaOctapharma’s core business is the development, production and sale of safe and effective medicines d...